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This paper summarizes the deliberations of a work group charged with addressing specific questions
relevant to risk estimation in developmental neurotoxicology. We focused on eight questions.
a) Does it make sense to think about discrete windows of vulnerability in the development of the
nervous system? If it does, which time periods are of greatest importance? b) Are there cascades of
developmental disorders in the nervous system? For example, are there critical points that determine
the course of development that can lead to differences in vulnerabilities at later times? c) Can
information on critical windows suggest the most susceptible subgroups of children (i.e., age groups,
socioeconomic status, geographic areas, race, etc.)? d) What are the gaps in existing data for the
nervous system or end points of exposure to it? e) What are the best ways to examine
exposure-response relationships and estimate exposures in vulnerable life stages? f) What other
exposures that affect development at certain ages may interact with exposures of concern? g) How
well do laboratory animal data predict human response? h) How can all of this information be used to
improve risk assessment and public health (risk management)? In addressing these questions, we
provide a brief overview of brain development from conception through adolescence and emphasize
vulnerability to toxic insult throughout this period. Methodological issues focus on major variables
that influence exposure or its detection through disruptions of behavior, neuroanatomy, or
neurochemical end points. Supportive evidence from studies of major neurotoxicants is provided.
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To address critical windows ofexposure that
impact neurological function, it is important
to recognize the importance ofmultiple fac-
tors. It is necessary to understand that these
windows of exposure are influenced by the
mechanism ofaction of the agent, the target
tissue dose of the agent, the developmental
time table ofthe target tissue, the end point
(outcome) ofinterest, and the age and man-
ner in which that outcome is evaluated
[Wilson (1) provides an introduction to
these now well-established principles].
Different functions are mediated by different
neural substrates, and the timing ofdevelop-
mental events varies with neural substrate.
Thus, vulnerability associated with specific
time periods of exposure varies with the
agent ofexposure and the end point ofinter-
est. It is also important to recognize the pro-
tracted period ofdevelopment ofthe nervous
system. The architecture and physiology of
the brain develop throughout gestation and
continue postnatally through adolescent
development. Insult at any point during this
period may result in aberrant neural structure
or function.
Specific aberrant outcomes have been
associated with particular windows ofvulner-
ability to specific agents: these developmental
windows begin before the formation of the
neural plate and end with pubertal neuromat-
uration. Most neurally active agents appear
able to disrupt development at multiple time
points across this broad protracted period.
Depending on the timing of exposure, the
end points affected may also vary. For a single
end point, however, there is often a period of
greatest vulnerability as defined by the pro-
duction of the outcome at a lower level of
exposure to the agent. The outcome itself
may be expressed only after (or perhaps at) a
particular developmental stage and may be
revealed only under certain conditions of
measurement. Natural conditions such as
aging or experimental conditions such as
social, pharmacological, or other environ-
mental challenges may be necessary to reveal
the deficit.
Inherent in the brain's protracted period
ofdevelopment, however, is also the phe-
nomenon ofneuroplasticity and the nervous
system's consequent potential forcompensation
after insult. Although it is important to
understand the role that compensatory mecha-
nisms may play in the manifestation of the
effects ofdevelopmental exposures, our view is
that the detection ofadverse outcomes at any
age is a primary goal ofscreening and risk
assessment, and transient as well as permanent
adverse effects need to be guarded against. For
this reason, we view an examination ofneuro-
plasticityas beyond the scope ofthis review.
The protracted period of development
and the protracted period over which out-
comes must be measured to adequately assess
dysfunction of the nervous system compli-
cate the establishment ofcausal relationships
in epidemiological studies ofdevelopmental
toxicity. Certain aberrations in development
are directly caused by exposure-based events
(e.g., abnormalities in the development of
the hypothalamic-pituitary axis), whereas
others may represent downstream conse-
quences of exposure (e.g., reduced body
weight, increased vulnerability to birth
trauma, altered responses to stress, and
decrements in learning and memory). It is
important to distinguish between primary
developmental aberrations caused by toxic
exposure and downstream effects. It is also
important to recognize that although there
are numerous outcomes of developmental
neurotoxicity, their expression (and measure-
ment) is limited to a finite set of readily
observable outcomes. Such abnormalities
may include specific aberrations resulting
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from diverse events, potentially emerging at
different times. Just as different mechanisms
may lead to grossly similar anatomical
expression (e.g., gross examination may not
distinguish missing tissue due to agenesis vs.
overactive apoptosis), different mechanisms
and primary neural abnormalities may lead
to similar behavioral manifestations (e.g.,
neurochemical dysfunction due to altered
neurotransmitter production or to altered
receptor dynamics may similarly alter behav-
ior). Functional alterations serve as apical
tests ofunderlying primary neuroanatomical,
neurophysiological, and/or neurochemical
abnormalities resulting from exposure.
The ease ofdetecting the primary under-
lying abnormalities varies with the resolution
ofthe technology. As a result, behavioral dis-
ruptions may sometimes be detected in ani-
mals or in children whose neuropathology
remains unidentified by standard means. The
failure to consistently identify neuroanatomi-
cal abnormalities in animals with behavioral
dysfunction has led to some investigators'
conceptualizations of robust behavioral
effects subtle. Although the extent to which
such effects may defy detection has merited
their being labeled subtle, the term should
not be used to imply milder. Ambiguity is
often present in the interpretation ofcertain
so-called subtle behavioral effects as poten-
tially mild when seen in rodents; the ambigu-
ity is easily resolved in human manifestations.
For example, identification of gross neu-
ropathology has not been consistently possi-
ble in studies ofmentally retarded children
(2); however, mental retardation would not
be considered a mild effect when produced
by a toxic exposure. Unfortunately, however,
the connotation of the "subtle" terminology
has, in part, led some to misinterpret the
model ofseverity of outcome, where frank
malformation is at one end of a continuum
and behavioral dysfunction at the other. This
has sometimes led to the incorrect conceptu-
alization ofdetectable anatomical changes in
any organ system as being more severe out-
comes ofexposure than behavioral impair-
ments, when dysfunction was not
accompanied by gross pathology ofthe brain.
For many compounds (ethanol, retinoic
acids, and valproic acid), the nature of the
dose-response relationships suggests that
higher doses are associated with outcomes such
as major malformations, whereas lower doses
produce behavioral change in the absence of
grossly detectable neuropathology. However,
many (perhaps most) environmental develop-
mental toxicants that influence behavioral,
hormonal, or growth outcomes do so in the
absence ofmalformation induction at higher
doses where maternal toxicity and/or fetal
death may occur [e.g., lead, mercury, poly-
chlorinated biphenyls (PCBs), amphetamine,
and cocaine]. Thus, in the context ofscreen-
ing, behavioral alteration may sometimes be
the only marker for risk assessment. Research
has clearly linked behavioral dysfunction with
ultrastructural or molecular abnormalities in
brain development; however, these end points
are not part ofcurrent screening approaches.
In this paper, we interweave empirical
evidence for our opening perspective with
our responses to the eight specific questions
provided as workshop directives. 1) Does it
make sense to think about discrete windows
of vulnerability in the development of the
nervous system? If it does, which time peri-
ods are ofgreatest importance? 2) Are there
cascades of developmental disorders in the
nervous system? For example, are there criti-
cal points that determine the course ofdevel-
opment, which can lead to differences in
vulnerabilities at later times? 3) Can informa-
tion on critical windows suggest the most
susceptible subgroups of children (i.e., age
groups, socioeconomic status, geographic
areas, race, etc.)? 4) What are the gaps in
existing data for the nervous system or end
points ofexposure to it? 5) What are the best
ways to examine exposure-response relation-
ships and estimate exposures in vulnerable
life stages? 6) What other exposures that
affect development at certain ages may inter-
act with exposures of concern? 7) How well
do laboratory animal data predict human
response? 8) How can all ofthis information
be used to improve risk assessment and
public health (risk management)?
Discrete Windows of
Vulnerability in Neural
Development
The first question considered at the work-
shop was as follows: Does it make sense to
think about discrete windows ofvulnerabil-
ity in the development of the nervous sys-
tem? If it does, which time periods are of
greatest importance? Empirical evidence
substantiates multiple periods ofvulnerabil-
ity to toxic insult in the developing nervous
system spanning from early gestation to ado-
lescence in humans and experimental animal
models (3-5). Toxic insults during this pro-
tracted period can result in diverse outcomes
ranging from structural abnormalities emer-
gent during early embryogenesis that may be
incompatible with pre- or postnatal survival,
to ultrastructural or molecular abnormalities
potentially emergent at any developmental
point and associated with functional deficits.
Wilson (1) originally described the manifes-
tations of abnormal development as repre-
sented by four main categories: death,
malformation, growth retardation, and func-
tional deficit. He also put forth as a princi-
ple of teratology that "manifestations of
deviant development increase in frequency
and degree as dosage increases from the
no-effect to the totally lethal level." Some
developmental toxicants that are capable of
disruption ofmorphogenesis through molec-
ular mechanisms demonstrate this conven-
tional neuroteratogenic profile whereby all
outcomes on the continuum of abnormal
development may be induced at different
stages and varying exposures [e.g., retinoids
(6,7)]. However, other developmental toxi-
cants that act through the disruption of
other morphogenetic signaling or neuro-
transmitter systems appear not to produce
gross malformations at doses below those
capable of producing maternal toxicity.
These agents produce robust effects that are
less readily detectable and less easily associ-
ated with narrow periods ofheightened vul-
nerability than is the case when gross
malformations are produced. Nevertheless,
the consequences may be equally robust.
Thus, multiple neuroanatomical, molecular,
and behavioral end points are necessary to
assess the effects of insult to the developing
nervous system. The windows of greatest
vulnerability to disruption of the neural
mediators of these various outcomes vary
with the agent of exposure, dose of the
agent, and its associated mechanism of
action, as well as the age at assessment and
other characteristics of the assessment
methodology. Thus, it makes sense to think
about discrete windows ofvulnerability only
when we recognize the importance ofother
variables. Empirical evidence demonstrates
that exposure during finite windows of
exposure produces quantitatively and quali-
tatively different outcomes. This has been
demonstrated not only in relation to multi-
ple outcomes of prenatal exposure but also
after exposure during different windows of
postnatal development in rodents [e.g.,
organotins (8-10)]. Thus, it makes sense to
think about windows ofvulnerability only in
the context ofa specific end point or set of
end points; otherwise, defining the most vul-
nerable period requires that outcomes be
evaluated according to a severity index. In
the case ofhazard identification for chemi-
cals in which limited data exist on mecha-
nism or mode ofaction or little information
is available in the literature examining criti-
cal windows ofexposure and developmental
effects, it becomes hard to assume what the
critical window ofexposure may be. In these
cases the default assumption could be that
the entire period ofneural development may
be vulnerable (i.e., beginning before neuru-
lation and ending after puberty). We first
consider the range ofend points necessary to
assess potential developmental effects oftox-
icity. We then address the windows ofgreat-
est vulnerability for effects on selected
outcomes. Finally, we discuss assessment
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characteristics that appear relevant to the
detection oftoxic insults.
NecessityofMultipleEnd Points
to Detect Potential Developmental
Neurotoxicity
Because developmental neurotoxicity can be
expressed through anatomical, physiologi-
cal, neurochemical and/or behavioral end
points, assessments of multiple end points
are necessary. Because there are a multitude
of measures for the study of structural or
functional effects of exposure, it is most
efficient to focus on more mainstream mea-
sures incorporated into screening studies
[reviewed by Meyer (11), Kimmel (12),
Adams (13), and the U.S. Environmental
Protection Agency (EPA) (14)]. We com-
pare screening methods with techniques
that have emerged as the most valuable
from a range ofscientific studies conducted
in the last decade. Studies in developmental
toxicology may examine anatomical and
gross physical end points along with behav-
ioral ones. Although behavioral measures
themselves have been limited in testing bat-
teries, they have nevertheless often been
more extensive than corresponding exami-
nations of neuroanatomical or neurochemi-
cal end points. In the context of screening
studies conducted in rodents, the need for a
battery of tests to measure functioning in
diverse behavioral systems has long been
recognized (15,16). The development of
behavioral testing batteries has received more
regulatory attention than has the need for a
sophisticated battery approach that includes
the examination ofcurrent neuroanatomical
or neurochemical/molecular end points.
More extensive measurement ofneural struc-
tures and neurochemical systems must be
incorporated with a more sensitive modern-
day behavioral screening battery. The inclu-
sion of neurochemical assessments during
critical periods of maturation and in adults
with prior developmental exposure may be
warranted in cases where chemicals affect
specific neurotransmitter systems in either in
vitro assays or in the adult nervous system
after exposure. This is predicated on the
qualitatively different role as neurotrophic
factors that neurotransmitter systems play
during development [reviewed by Buznikov
et al. (17) and Rice and Barone (18)].
Behavioral test batteries generally contain
measures of viability, growth, and physical
developmental landmarks along with mea-
sures of motor development, sensory func-
tioning, activity levels, reactivity, and
learning and memory. The rationale for this
screening battery approach emphasizes that
different agents and exposures at different
times to the same agents result in effects on
different systems measured within the battery
(19,20). Because most regulatory approaches
to screening have incorporated relatively long
exposure windows, assessing a multitude of
potentially vulnerable systems is paramount.
In the context ofwindows of vulnerability,
we must always recognize that the window of
greatest vulnerability may vary with the end
point under examination. If the relevant
end point is not examined, the effects will
not be detected. Likewise, ifthe relevant end
point is inadequately assessed, effects may
not be evident.
Use of the battery approach in the last
decade has reinforced the need to assess the
categories of functioning but has challenged
the value ofor suggested more valuable mea-
sures within each category. Also, routine
incorporation of other methods in research
studies has demonstrated the value ofexamin-
ing other end points.
Distinctive Neural Systems Have
DifferentPeriodsofVulnerability
Different areas ofthe brain mediate different
types of information processing and are
related to different kinds of neural function.
Whereas all neural processing involves multi-
ple neural centers and major pathways con-
necting specific structures, it is heuristic to
recognize certain critical sites. Rice and
Barone (18) discuss the following areas in
their background paper: prefrontal structures
for working memory and executive func-
tions; medial temporal lobe structures for
certain aspects oflearning and memory; and
brainstem structures for regulation of
arousal, sleep-wake cycles, and multiple
autonomic nervous system functions. Each
area has its own protracted period during
which neurogenesis, migration, specification,
elaboration of neurons, apoptosis, and inter-
nal synaptic connectivity as well as establish-
ment ofinput/output circuits take place. The
background paper by Rice and Barone (18)
and a review by Holson (21) provide infor-
mation on specific time periods for different
brain areas. Jensen and Catalano (22) pro-
vide an overview of nervous system morpho-
genesis; their overview is a primary source for
this limited extraction. In light ofbrain area
and circuit-dependent differences in the tim-
ing ofdevelopmental events, it is not surpris-
ing that behaviors mediated by different
brain systems would be disrupted by insults
at different times during development. It is
also not surprising that disruption of some
embryonic developmental events results in
gross malformations as a consequence,
whereas more commonly, developmental
insults result in cytoarchitectural or molecu-
lar alterations. Therefore, the particular agent
and end point under investigation will deter-
mine the temporal window identified as
most vulnerable to insult.
NeuralVulnerability SpansfromEarly
in GestationthroughAdolescence
A series of developmental events appear to
define periods of greatest vulnerability to
insult. These developmental events occur at
different times for different neural struc-
tures and circuits. Thus, there is no simple
categorization ofmorphogenesis ofthe cen-
tral nervous system into discrete temporal
nonoverlapping categories. Therefore, our
discussion ofvulnerable windows is kept very
broad, instead emphasizing the protracted,
interactive, and temporally overlapping
nature of stages and major morphogenetic
events. Our discussion incorporates the
embryonic, fetal, and early postnatal periods
of brain development, then focuses on ado-
lescent brain development. We provide sup-
portive evidence for disruption of different
processes and events for selected agents.
Vulnerability before induction ofthe
neuralplate through neural tube closure
andformation ofthe rhombencephalon.
The period in human pregnancy that occurs
before the induction of the neural plate is
before day 18 postconception. In the rat, this
period is before day 9. Toxic disruption of
developmental events prior to neural induc-
tion has been demonstrated after early expo-
sures to diabetic conditions, retinoic acid,
methylnitrosourea, and clomiphene [reviewed
by Bennett and Finnell (23)]. Such exposures
resulted in an increased incidence of neural
tube defects and certain other malformations
despite exposure before neurulation.
Better understood, however, are the
effects of toxic agents during the neurulation
process itself (human: approximately days
18-28, rat: approximately days 9-12) primar-
ily in regard to insults that result in death or
neural tube defects qualifying as major mal-
formations (6,22,23). Such malformations
include anencephaly, spina bifida, encephalo-
celes, and myelomeningoceles. Classic terato-
gens include retinoic acid, arsenic, and
valproic acid as well as hyperthermia [retinoic
acid was reviewed by Adams (6) and Adams
and Holson (7); other agents were reviewed
by Bennett and Finnell (23)]. These agents
appear to evoke diverse mechanisms that
result in neural tube defects as a final com-
mon, categorically similar outcome.
Abnormalities other than the classic mal-
formations can also result from exposures
before and around neural tube closure,
around the time of rhombomere formation
(23,24). Effects on hindbrain structures such
as brainstem and cranial nerve nuclei are
clearly demonstrated by exposures to valproic
acid and thalidomide (24,25). Effects on
brainstem, cranial nerve nuclei, and cerebellar
structures have also been shown after expo-
sures to retinoic acids (7,26-29). Early on,
these agents were associated with behavioral
Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000 537ADAMS ETAL.
deficits in the absence of identified
neuropathology [retinoic acid was reviewed
by Adams (6) and Adams and Holson (7);
valproic acid was reviewed by Dansky and
Finnell (30), Finnell and Dansky (31), and
Hansen and Holson (32)].
Brain development after neural tube
closure: vulnerability in multipleprocesses
and events that are interactive and over-
lapping. Morphogenesis of the nervous
system begins with the induction of the
neural plate and continues into postnatal
development. Although neurogenesis was
originally believed to end during the early
postnatal years in humans, it is now recog-
nized to be present to a limited degree
throughout life [reviewed by Kempermann
and Gage (33)]. Nevertheless, extensive neu-
rogenesis is limited to early development in
humans, and in rats appears to encompass
gestational days 11-22, except the hippocam-
pal and cerebellar microneurons, which
develop postnatally in the rat (21). During
early stages, the segmented brain first devel-
ops into a trivesicular organ that includes the
rhombencephalon, mesencephalon, and pros-
encephalon. The migration ofneurons even-
tually results in the formation ofall structures
ofthe brain. During this extended period of
morphogenesis, multiple processes occur that
are necessaryfor thedevelopment ofneuronal
and glial elements and their complex cir-
cuitry. Intra- and intercellular interactions
involving multiple trophic agents constantly
act to create, shape, and then remodel the
brain and nervous system. Clearly, descrip-
tions of these developmental events are
beyond the scope ofthis paper. A detailed
overview ofthe processes and events ofbrain
development can be found in Jensen and
Catalano (22). Rice and Barone (18) discuss a
temporal characterization ofprocesses such as
proliferation, migration, synaptogenesis, glio-
genesis and myelinogenesis, and apoptosis in
relation to particular brain areas. Barone (34)
and Barone et al. (35) provide more extensive
reviews ofprocesses, signaling, and trophic
molecules involved in development. Of
importance here is the fact that toxic interfer-
ence with these fundamental developmental
processes and multiple signaling and trophic
agents has been well documented to result
not just in malformations, but more com-
monly in cytoarchitectural and molecular
alterations that are expressed as behavioral
dysfunction. For environmental agents associ-
atedwith long-term exposure patterns, behav-
ioral, neuronal, or molecular effects have been
associated with a greater number ofagents
than have the early developmental malforma-
tions associated with classic teratogens. Thus,
environmentally relevant levels oflead, mer-
cury, pesticides, PCBs, and many other
agents pose a greater threat to perturbation of
developmental processes like synaptogenesis
than to expressions of insult through gross
malformations. Herein lies the dilemma:
qualitative histological examination ofNissl-
stained sections ofthe brain (as required by
some guidelines) does not adequately assess
neuroanatomical and neurochemical charac-
teristics with the resolution necessary to
detect these changes. Morphometric analysis,
at least on a regional level during brain devel-
opment, can provide some estimates ofdelays
in synaptogenesis or persistent alterations in
synaptogenesis and/or dendritic elaboration
[reviewed by Barone et al. (35)]. Likewise,
some methods ofevaluating alterations in
behavior or other neurological functions may
be inadequate to detect many subtle effects.
This could be critical for child health protec-
tion ifsubtle effects in animals are missed or
in some instances dismissed because they are
onlyobserved in the highest dose group under
study and are possibly confounded with
indices ofmaternal toxicity. Let us consider
lead and methyl mercury toxicity to illustrate
the relationship among neuroanatomical, neu-
rochemical, and behavioral effects. These
agents were selected because oftheir historical
prominence, their relevance to regulatory
actions, and the extent ofavailable data. They
allow discussion notonlyofoutcomes but also
ofprimarysubstrates that areaffected, and also
illustrate some age-dependent vulnerabilities.
Broader discussion can be found in Rice and
Barone (18), Dietrich (36), and Bellinger and
Dietrich (37).
Lead. Lead is a good example ofa devel-
opmental toxicant whereby under condi-
tions of long-term, low-level exposure,
behavioral disruption is the primary out-
come. Bellinger and Dietrich (37), Dietrich
et al. (38), and Rice (39,40) published excel-
lent reviews on this subject. Exposures that
are mostly postnatal and often restricted to
infancy (substantiated in these reviews) as
well as prenatal exposures (41) have been
associated with the production of general
intellectual deficits as well as deficits in spe-
cific sensory and cognitive abilities. The
fetuses and children appear more susceptible
to these effects than adults. Effects on gross
brain structure have not been evident in
studies directed at understanding underlying
neuropathology associated with low-level
lead exposure. Instead, the effects most con-
sistently noted are those on synaptogenesis
and dendritic arborization (42-46), in vivo
physiological examinations ofsynaptic plas-
ticity (47-49), and decrements in myelina-
tion (50,51). Changes in glutamate and
y-aminobutyric acid synthesis and release
(52,53) and the glutamate N-methyl-D-
aspartate (NMDA) receptor levels and bind-
ing affinities have also been reported in
association with low-level lead exposure
(54). Direct inhibitory actions of lead on
NMDA receptors in the hippocampus have
also been associated with and used to explain
synaptic changes as well as cognitive impair-
ments in lead-exposed rodents and children
(54). Thus, lead exposure can disrupt devel-
opmental events that begin prenatally but
continue during early childhood, and can do
so at multiple points during that interval.
Methyl mercury. Because ofthe poison-
ing at Minamata Bay, Japan, in the mid-
1950s, the results ofhigh- as well as lower
level exposures to methyl mercury have
received a great deal ofresearch attention. As
was the case for lead, the fetus and child are
more susceptible to methyl mercury toxicity
than adults [reviewed by Chang et al. (55)
and Burbacher et al. (56)]. Burbacher et al.
(56) examined the comparative characteristics
of methyl mercury exposure to developing
humans, macaque monkeys, and rodents.
They showed clear dose-response effects for
behavioral as well as neuropathological end
points that were quite consistent across
species. Effects were examined across low (< 3
ppm), moderate (3-11 ppm), and high
(12-20 ppm) doses defined by brain tissue
content. Dose-related effects on behavioral
outcomes were manifested as cognitive
deficits or delayed development at low doses,
cognitive and sensory electrophysiological
effects at moderate doses, and severe sensory
(blindness), cognitive, and motor (spasticity)
abnormalities as well as seizures at high doses.
Neuropathological effects in rodents exposed
across these dose ranges included cellular loss
and decreased brain size at low doses,
decreased brain size, cortical and cerebellar
defects, and reduced myelin at moderate
doses, and these same effects plus effects on
additional brain structures at high doses.
More recent work has identified disruptions
in neuronal proliferation and migration, dys-
myelination, hypoplasia ofthe corpus callo-
sum, and hydrocephalus in association with
high doses; lower level exposures have been
associated with migration and cytoarchitec-
tural defects (57). Mediation oftoxic effects
on neural development may involve alter-
ations in cell adhesion molecules and
cytoskeletal proteins (56) and neurotrophic
factorsignaling (58-60).
Vulnerability during the adolescent
period ofdevelopment. In addition to the
dramatic neuroendocrine and physical
changes associated with adolescence, from
even the limited amount ofliterature avail-
able, it is clear that the brain ofthe adoles-
cent also undergoes striking transformations.
Several brain regions undergo prominent
remodeling during adolescence across a vari-
ety ofspecies. These regions include the pre-
frontal cortex and other forebrain regions to
which mesolimbic dopaminergic terminals
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project. In addition to an adolescent-
associated decline in the volume ofthe pre-
frontal cortex [humans (61); rats (62)], there
is also substantial synapse elimination ofpre-
sumed glutaminergic excitatory input in
motor cortex (63) while dopaminergic input
to the prefrontal cortex increases during ado-
lescence to reach levels higher than that seen
earlier or later in life [reviewed by Lewis
(64)]. Estimates of basal synthesis and
turnover ofdopamine decline in prefrontal
cortex during adolescence in rats, which con-
trasts with the increase in these measures
reported in the nucleus accumbens and stri-
atal dopamine terminal regions ofadolescent
rats (65,66). Maturational events have also
been reported in a variety of other areas
including the hippocampus [humans, (67);
rodents, (68), and hypothalamus (69)].
These data suggest that the adolescent
period ofbrain development should be a time
ofparticular vulnerability to insult. However,
there has been surprisingly little investigation
in either humans or animals ofthevulnerabil-
ity ofadolescent brain to developmental per-
turbation. Some studies in experimental
animals have begun to address this data gap.
Salimov et al. (70) reported that ethanol con-
sumption by adolescent alcohol-preferring
rats altered later behavioral responsiveness to
novelty and a swim stressor. Goliszek et al.
(71) reported that long-term stress of rats
from 4 to 10 weeks ofage [a period that the
authors defined as prepubertal but which
should span the entire pubertal period
(72,73)] permanently altered the animal's
ability to release adrenocorticotropic hor-
mone, even when subjected to considerable
stress; males were particularly vulnerable in
this regard. These few examples clearly
demonstrate that explorations ofthe conse-
quences of insults during adolescent brain
development remain unexplored territory that
should be quite fertile for future research.
The detection ofthe effects ofdevelop-
mental toxicity can be optimized by atten-
tion to specific assessment characteristics.
Studies in developmental toxicity have
shown not only a protracted period ofvul-
nerability but also a protracted period over
which the consequences are expressed.
Whereas one can simply say, for example,
that the behavior or neural system must first
have developed before its integrity offunc-
tion can be examined, the issue is far more
complex. Among issues ofimportance are a)
neural mediators for particular behaviors
sometimes change with age, experience, or
the need for compensation; b) vulnerability
may vary with the sex ofthe individual; and
c) effects may only be detectable under more
challenging conditions. Data illustrating
these issues can be found in the background
paper by Rice and Barone (18).
These issues have been recognized for years
and now cumulative evidence demands
increased attention to the age ofassessment.
The research issue to be resolved is whether
testing in screening studies ofyoung adult
experimental animals alone is adequate to iden-
tify long-term consequences ofdevelopmental
perturbations. We focus only on the issue of
improved detectability under challenging con-
ditions. There are five approaches that could
reveal the subclinical long-term effects of
developmental exposure, wherebydetectability
is revealed through a) aging-related functional
or morphological loss, b) pharmacological
challenge to the integrity ofa particular neu-
rochemical system, c) response to environ-
mental stressors, d) increased task
complexity, or e) histological examination of
the brain that includes quantitative assess-
ments at different life stages. Long-term con-
sequences of chemical exposure during
development could be examined in an
adjunct way in screening studies evaluating
exposure over the lifetime in multigenera-
tion-reproductive screening studies.
Methyl mercury was the first compound
to draw considerable attention to the phe-
nomenon ofdevelopmental exposures mani-
festing effects revealed with aging (18,74,75).
Animal and human studies have identified
motor and sensory deficits with increasing age
that were not seen at earlier time points after
the cessation ofexposure as well as a worsen-
ingofconditions with age. Byway ofcompar-
ison to another agent, rats exposed to
triethyltin during early postnatal development
demonstrated decrements in cognitive perfor-
mance at 24 months ofage that were not seen
at 3 months ofage and at 1 yearofage (76).
Pharmacological challenges have been
widely used in animal studies to examine
functioning in specific neurochemical systems
[reviewed by Meyer (11)]. Such challenges
serve as probes to evaluate the integrity of
particular systems that are pharmacological
targets ofthe developmental toxicant under
study or that influence behaviors under study.
Generally, agonists, antagonists, or agents
that up-regulate or down-regulate the trans-
mitter system are used. Historically, drug
challenge studies have been commonly used
to examine changes in activity, body tempera-
ture, tremor, forepaw treading, head weaving,
or threshold for catalepsy. These studies by
inference reflect changes in neural connectiv-
ity and neurotransmission.
Increased sensitivity to various environ-
mental stressors has also been seen in animals
exposed to developmental toxicants. For
example, the review by Spear et al. (77)
showed that rats prenatally exposed to
cocaine have increased sensitivity to stressors
such as early manipulation, social competi-
tion, and immobilization.
Animal models ofmultiple human mental
retardation disorders have demonstrated the
difficulty ofmost assessments oflearning in
rats in capturing expected deficits, in part
because of the simplicity of routinely used
measures oflearning and memory in rodents.
Task complexity unmasks various learning
deficits (78,79). Cumulative learning tasks
that require transfer of training experience
appear particularly useful in revealing learn-
ing deficits. This has been demonstrated in
multiple studies using operant schedules of
increasing complexity to examine deficits in
animals [reviewed by Rice and Barone (18)
and Paule et al. (80)]. Examinations of the
ability to shift or reverse learning rules pro-
vide added detection sensitivity in nonoper-
ant tasks such as versions ofthe water maze
and other tasks (19,81). Finally, learning
methods that make demands on working
memory, such as delayed alternation tasks
[reviewed by Rice and Barone (18)] or other
tasks that require timing or inhibition of
responses [reviewed by Paule et al. (80)],
appear to offer increased sensitivity. These
types offunctional assessments can be more
sensitive to perturbation of the development
ofthe nervous system than tasks that use only
simple acquisition ofspatial learning or one-
trial learning tasks (e.g., active avoidance or
passive avoidance tasks).
Developmental Effects May
Unfoldthroughout Life
Ar There Critical PointsThat
Determine theCourseofDevelopment
ThatCan Leadto Differences in
Vulnerabilities atLiterTunes?
We have emphasized a sequence ofdevelop-
mental events that are interrelated, and we
also emphasized that functional effects
unfold throughout the lifespan. Certain
effects become evident only as relevant func-
tional capacities emerge. Other effects mani-
fest with declines in reserve capacities that
become functionally expressed subsequent to
aging or under more challenging test condi-
tions. Because the brain and behavior are
constantly influenced by experience, any
alteration in the integrity of nervous system
function at one point in time predisposes a
risk to the ongoing and future integrity of
the structure and function ofthe nervous sys-
tem. In this sense, cascades of effects are an
unavoidable consequence ofthe prime direc-
tive ofnervous system functioning: the con-
tinual adaptation to environmental change
through constant processing of information
and neural remodeling.
Because of the cascade of effects that
exposure can have on development and func-
tion ofthe nervous system, sometimes there is
debate regarding which behavioral effects are
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primary and which may be secondary
consequences or downstream manifestations.
For example, we may wish to determine ifall
children with comparably reduced intelli-
gence have correspondingly reduced attention
spans, or ifa particular genetic disorder, dis-
ease, or agent appears to more selectively tar-
get neural substrates for attention. In a
risk-assessment environment, all detrimental
effects collectively represent effects to be
avoided. When cause-effect relationships
need to be scientifically understood forseveral
different behavioral outcomes, however, or
when intervention may be used to mitigate a
known cascade, it is useful to be able to tease
primary and secondary effects apart. Primary
effects are manifest on neural architecture or
physiology but may be expressed most
notably on altered behavioral functioning.
Certain behaviors are more proximal to the
neural effect caused by exposure than others.
For example, certain agents appear to alter
attention span, impulsivity, or activity levels
in children. As a subpopulation, children with
poor impulse control (for whom most etiolo-
gies are unknown) are at increased risk for
poor academic performance and accidents, for
the development ofsubstance abuse disorders,
and even for criminal activity [reviewed by
Pennington (82)]. These downstream out-
comes have high societal costs and may occur
with increased risks in children exposed to a
variety of developmental toxicants (18).
Knowledge ofthe relationship between the
antecedent problems in impulse control and
the increased risk for later manifestation of
other sociobehavioral problems can be helpful
in channeling children and their families into
intervention programs to try to reduce future
correlated manifestations. It is difficult to fully
parse the effects oftoxic exposure on child-
hood impulsivity versus increased criminality
because nonexposure-related variables might
intervene to determine the progression from
impulsivity to criminality. Ifwe wish to asso-
ciate the effects ofa developmental toxicant
with a downstream manifestation ofthis type,
we must design studies that attempt to further
address the intervening variables of impor-
tance (educational characteristics and family
and home characteristics). Research must not
only compare exposed children to demo-
graphically matched nonexposed children but
should also contrast the long-term behavioral
characteristics ofexposed children with those
of children with similar early behavioral
characteristics (like impulsivity) not due to
exposure. This would allow determining
agent-specific versus more generic behavioral
profiles present in all children with predispos-
ingpersonal and familial riskfactors.
In addition to the interrelated events that
determine each stage ofnervous system devel-
opment and the functional cascades described
above, it is important to recognize that
developmental exposure to certain agents may
also alter later physiological or neurochemical
responses. For example, prenatal exposure to
cocaine (66,83,84) alters later pharmacologi-
cal sensitivity to dopaminergic agents as well
as to ethanol (85).
Information on Critical
Windows May Suggest
Susceptible Subgroups
ofChildren
Neurobehavioral characteristics ofchildren
are influenced by parental socioeconomic sta-
tus, parental age, educational background,
and ethnicity. These important variables
must be controlled through experimental
design or statistical procedures whenever
neurobehavioral outcomes are examined.
Further, infant characteristics such as sex,
small-for-gestational-age status at birth, and
the presence ofbirth complications increase
the risk for compromised motor or intellec-
tual development. This presents a dilemma
for associating early exposures with adverse
neurobehavioral effects, particularly when
the exposure reduces birth weight, increases
prematurity, and/or complicates the birth
process in other ways. At the screening level,
we deem it fully acceptable for the entire cas-
cade of events to be viewed as increased
because of exposure and therefore believe
that it represents effects that we would wish
to avoid for any environmental agent.
However, it may also be important to deter-
mine if the full cascade ofeffects is proto-
typical in incidence and generic to any child
born with comparably reduced birth weight,
comparable prematurity, or a comparable
experience of another birth complication.
This determination can be answered only
through studies with appropriate contrast
groups as well as control groups.
Gaps in Existing Data
Previous discussion has emphasized the need
for a) screening-level assessment ofcytoarchi-
tectural aspects ofneuroanatomy and molec-
ular aspects of function, b) expanded
knowledge ofpreembryonic exposure effects,
nonmalformation outcomes after embryonic
exposure, as well as effects consequent to
exposures during adolescence, and c) develop-
ment, validation, and incorporation ofmore
sensitive methods to assess learning and
memorywithin ascreening context.
The issue ofhazard characterization of
anatomical effects after developmental expo-
sure continues to be a problem ofwhere and
when to look for alterations. Histological
examination using both qualitative and quan-
titative examination during development and
into adulthood can reveal adverse effects after
developmental exposure during different
critical periods (58,76,86). Currently, screen-
ing approaches, including examination of
representative structures ofthe brain that
develop both prenatally and postnatally, are
required under the U.S. EPA testing guide-
lines for developmental neurotoxicity (14).
This guideline was designed in the late 1980s
with apical measures in mind. As more data
become available using this guideline and
newer methods are developed, this guideline
for screening chemicals for developmental
neurotoxicity could and should evolve. A
number ofpractical considerations and scien-
tific issues will probably influence the devel-
opment ofnewer testing strategies. First, as
an example ofthe practical issues, there are a
large number ofhigh production/volume
chemicals (approximately 3,000) that have
not been examined at all for developmental
neurotoxicity (87,88). This issue, among oth-
ers, suggests that alternative means oftesting
and/or prioritization oftesting may need to
be used. The Endocrine Disruptor Screening
and TestingAdvisory Committee is an exam-
ple of this approach based on the develop-
ment and evaluation ofa battery of in vitro
and in vivo tests with a scientifically sound
mechanistic basis. Currently, a number of in
vitro tests are available for testing different
processes critical to development ofthe ner-
vous system such as proliferation, differentia-
tion, and apoptosis; however, little
coordination ofresources has been devoted to
the validation and application ofsuch tests as
adjuncts to a developmental neurotoxicity
screeningbattery for testing chemical hazards.
In addition to hazard identification and pre-
liminary screening, these tests could serve to
provide some mechanistic underpinning for
how a chemical or class ofchemicals affects
development ofthe nervous system. Develop-
mental neuroscience has provided a rapid
expansion ofinformation about the genetic
and epigenetic control of developmental
processes. The use ofboth in vitro culture
models derived from rodents and human
stem cells and immortalized neurons derived
from humans may facilitate comparisons of
chemicals on the basis ofeffects on develop-
mental processes critical to normal vertebrate
brain development. Identifying the effects
related to aggregate and cumulative exposures
during development ofthe nervous system is
complex; however, future research could
examine these developmental processes both
in vitro and in vivo with the goal ofidentify-
ing the chemical's mode ofaction in a way
that could be extrapolated across species.
Additionally, consideration ofthe chronic
versus acute nature ofpotential human expo-
sures and ofrelevant pharmacokinetic infor-
mation should be utilized in the design of
dosing schedules used in screening studies.
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Finally, there is a need for development of
animal screening methods that evaluate social
and emotional functioning and a need for
incorporation ofassessments ofmental health
functioning into human studies. Conversely,
there is a need to determine the role ofdevel-
opmental insult in the etiology ofhuman psy-
chiatric disorders through research on these
populations. The reconceptualization of
schizophrenia as a neurodevelopmental disor-
der has occurred over the last decade because
ofepidemiological studies addressing prenatal
and adolescent variables (89-94). Also,
insights into the etiology ofautism have been
gained through evaluation ofthe consistency
between symptomatology and the disruption
ofearlyembryogenesis (24).
Examinations and Estimation
of Exposure-Response
Relationships
It is important that laboratory studies model
real-world exposure characteristics as closely
as possible. To this end, information about
the phasic versus tonic nature ofexposure
and the corresponding pharmacokinetic
characteristics of the agent must be taken
into account whenever possible as a means of
strengthening the design ofscreening studies.
When exposure characteristics provide an
appropriate model of the human exposure
scenario, responses to exposure can then be
measured with all of the recommendations
and caveats that have been a major focus of
this paper.
This posed question is more formidable
in the context of human epidemiological
studies. Outside ofthe laboratory environ-
ment, exposure assessment in epidemiologi-
cal studies is challenging because these
studies lack simplified quantification to
address issues related to age-based vulnerabil-
ity and this assessment is often precluded by
the large numbers of individuals necessary
to permit breakdown into multiple age
groups. Although power calculations can pro-
vide reasonable estimates ofthe numbers of
people necessary to get reliable results, esti-
mates are more accurate when preexisting
data are available to identify the end point(s)
ofinterest and the magnitude ofthe effect to
be reasonably expected. When the effect is
easy to measure or to quantify, this makes it
simpler to use the minimum number ofpar-
ticipants determined using the power calcula-
tions. Otherwise, larger sample sizes need to
be used to attempt to find less readily
detectable effects. Aside from difficulties
inherent in satisfying sample size needs, how-
ever, there are greater complications associ-
ated with estimating exposure and measuring
the outcome ofinterest. Although estimating
exposure based on careful interview tech-
niques along with determinations of local
residual environmental contamination and
residues in human tissues is possible but
problematic, it has been more problematic to
associate exposures with narrow developmen-
tal time periods. Nevertheless, this may be
necessary to optimally estimate risks that are
highly stage dependent. When the environ-
mental or occupational contamination is
confined to a particular time period, studies
could attempt to parse the exposed partici-
pants into groups differing according to bio-
logically meaningful periods of exposure.
Provided that adequate sample sizes could be
used, selection ofgroups according to ongo-
ing developmental events at the time of
exposure might improve the ability to
address exposure-response events. In other
words, detectability might be optimized
under conditions where the biological plausi-
bility ofthe cause-effect relationship under
study is maximized by narrowing the win-
dow ofexposure to the most vulnerable stage
ofdevelopment. When groups include par-
ticipants exposed outside of the period of
greatest vulnerability for disruption of the
end point ofinterest, the presence of these
added participants could dilute the ability to
detect the effect. Thus, a trade-offbetween
sample size and sensitivity of the design is
always present and must be carefully consid-
ered. This issue is ofparamount importance
in studies where major malformations are the
end points ofinterest.
Itis also critical thattheoutcomeofinterest
be examined with attention to a number of
potential moderating variables. It is impor-
tant to design studies that address the interac-
tive effects ofvariables that may affect the
results, such as socioeconomic status, parental
smoking, alcohol, or illicit drug use, as well as
use ofprescription or over-the-counter com-
pounds. Human lead studies [reviewed by
Dietrich et al. (38)] have paid a great deal of
attention to these variables, as have some
human studies of substances of abuse
[reviewed by Rice and Barone (18) and
Richardson and Day (95)].
Launching new large-scale, prospective,
longitudinal studies ofdiverse groups ofchil-
dren and pregnant women would provide
sound information from which the effects of
various exposures on sensory, motor, cogni-
tive, emotional, and mental health outcomes
could be measured. Regular blood or tissue
sampling from the participants could provide
a database from which numerous questions
could be asked about developmental expo-
sures to specific agents. Such an ambitious
undertaking, however, would be quite costly
and lengthy. Nevertheless, the greatest benefit
would be derived from a prospective compre-
hensive design.
The limitations of retrospective designs
generally compromise the quality of the
information obtained. Nevertheless, a very
useful initial approach to addressing many
questions about developmental toxicity
involves the use ofexisting databases. Many
very large studies, such as the Collaborative
Perinatal Project (96) (a prospective longitu-
dinal study) and the National Health and
Nutrition Examination Study (NHANES)
(90) (a cross-sectional study), have been con-
ducted. NHANES periodically surveys a
sample of the U.S. population to assess a
large number ofhealth parameters and bio-
logical measures. Thus, a database ofques-
tionnaire responses and a large collection of
stored serum, urine, and other specimens
exist for this population. NHANES IV is
currently in the data collection phase, and
should provide the greatest range to date of
specimens from the entire U.S. population.
These stored banks ofbiological specimens
could serve as valuable resources for investi-
gators who are not able to launch a com-
pletely new study. With respect to behavioral
outcomes, however, they are somewhat
limited and would no doubt demand addi-
tional data collection. Ofparticular value to
neurodevelopmental toxicity studies are
Scandinavian databases (90) that contain
extensive health records, extensive educa-
tional records, and scores on measures of
intellectual functioning.
Other Exposures May Interact
with Exposures of Concern
In human populations, the prevalence of
caffeine, cigarette, and alcohol use complicate
the study ofspecific toxic agents in the envi-
ronment. Similarly, diets ofvarying nutri-
tional quality and the use of commonly
prescribed psychoactive drugs or hormones
may interact with the assessment ofrisks of
exposure to environmental agents. Therefore,
it is important to determine the usage of
common substances when human experimen-
tal or epidemiological studies are done. In
studies ofdevelopmental neurotoxicity, the
influence ofmany of these variables on the
effects of nonelective exposures has been
addressed through statistical means:
Information is generally obtained via ques-
tionnaire and used as a covariate. Excellent
examples and descriptions of these
approaches can be found in reviews by
Bellinger and Dietrich (37), Dietrich et al.
(38), Richardson and Day (95), and Fried
and Makin (97).
Laboratory Animal Data
Predict Human Responses
Many conferences, symposia, and individual
publications have addressed the issues sur-
rounding the predictive value ofrat and pri-
mate studies to humans. Ofparticular interest
has been how well animal behavioral data
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predict human behavioral responses. Efforts
to address this question have generally chosen
specific agents and categories ofend points,
then looked for concordance in the demon-
stration ofeffects within each category. When
focusing on the extrapolation of animal
behavioral data, evaluations have been made
of the effects ofspecific neurotoxicants on
functional categories such as general develop-
mental landmarks, sensory, motor, learning
and memory, and social behavior (98,99).
This approach suggests that reliable and valid
animal data predict human responses very
well. For example, agents that disrupt
sensory-evoked potentials and other electro-
physiological parameters in humans produce
similar disruptions in rats and primates
(18,100). Further, behavioral dysfunctions
tend to depend on similar neural substrates
across species. Thus, the specific behavior dis-
rupted in one species can be linked to alter-
ations in particular neurobiological substrates
that also mediate a similar category ofbehav-
ior in humans (18,21).
Nevertheless, within the context ofmeth-
ods used in screening batteries, extrapolation
appears strongest with regard to effects on
sensory and motor functioning, and is some-
what less strong for cognitive or social func-
tioning. We emphasized the need to further
challenge the integrity of learning mecha-
nisms through task complexity as a means of
improving screening-level detection of
deficits in learning and memory. Whereas
models of social behaviors such as infant
suckling, maternal-infant interactions, or
reproductive behavior appear to produce
concordant effects across species, more com-
plex aspects ofhuman social behavior have
not been modeled in animal studies ofdevel-
opmental toxicity. Likewise, approaches to
assessing animal behavioral end points that
adequately screen for potential effects on
emotional or mental health end points have
not been broadly applied. As the neuro-
biological understanding of mental health
disorders has expanded, it has become clear
that altered brain development may predis-
pose individuals to increased vulnerability to
stress and mental health disorders (89,90).
More attention to this research issue is
needed in both animal and human develop-
mental toxicity studies.
Implications for Risk
Assessment and Public Health
We emphasized certain shortcomings of
current screening approaches and epidemio-
logical studies, certain methodologies that
appear to be more sensitive in identification
ofdevelopmental neurotoxicity, and the need
for improved understanding of toxicity dur-
ing certain vulnerable periods or on certain
end points. Some of our discussion can be
translated into immediate actions, whereas
other points emphasize longer term goals that
demand more research and data before appli-
cation. Explicitly, we suggest the following:
* In rodent screening studies, when back-
ground data are not available on the
agent, allow a broad exposure window
from fertilization through adolescence for
agents that would have an extended expo-
sure period in humans.
* Use pharmacokinetic data and human
exposure characteristics to determine the
logical window ofexposure for use during
screening studies aimed at risk assessment.
* When plausible and logical given the real-
world exposure situation, interweave mor-
phological and functional testing into
multigenerational studies to cover the full
spectrum of development (i.e., womb
to tomb).
* Determine the nature ofdevelopmental
neurotoxicity following exposures before
the induction ofthe neural plate and dur-
ing the adolescent period.
* Use more contemporary and sensitive
methodologies for evaluating behavior
when the methodologies are amenable to
the screening context-add prepulse inhi-
bition to the startle paradigm, improve
water maze learning tasks by the addition
ofreversal learning, and examine morpho-
logical and functional effects in young as
well as aged animals.
* Develop measures ofcumulative learning
that are amenable to the screening context
and determine ifthese are more sensitive
than the basic learning tasks currently
used.
* Increase the use of neuropathological
assessments to cover the broader spectrum
ofdevelopment ofthe brain. This could
be performed in screening studies with
the examination ofthe brain in both tera-
tology and multigenerational study proto-
cols. It could also complement other work
performed in developmental neurotoxicity
screening studies.
* Develop screening techniques that exam-
ine cytoarchitectural and molecular
aspects ofnervous system functioning.
* Examine the relationship between
sensitive measures of neuroanatomy,
molecular functioning, and behavioral
compromise (with the long-term goal ofa
viable tiered approach to the selection of
agents for behavioral evaluation based on
altered neural structure or molecular
characteristics).
* Use biological plausibility for causation of
the outcome of interest to narrow the
developmental periods now examined in
epidemiological studies.
* Perform preliminary examinations of
developmental neurotoxicity in humans
and seek concurrent validation of results
through the examination ofdata derived
from larger samples available in existing
databases.
* Initiate human prospective and longitudi-
nal studies that collect tissue samples as
well as neuropsychological data.
REFERENCES AND NOTES
1. Wilson JG. Environment and Birth Defects. NewYork:Academic
Press, 1973.
2. Schaefer GB, Bodensteiner JB. Evaluation ofthe child with idio-
pathic mental retardation. Pediatr Clin North Am 39:929-943
(1992).
3. Kimmel CA, Buelke-Sam J. Developmental Toxicology. New
York:Raven Press, 1981.
4. Slikker WJ, Chang LW. Handbook of Developmental
Neurotoxicology. San Diego:Academic Press, 1998.
5. Riley EP, Vorhees CV. Handbook of Behavioral Teratology. New
York:Plenum Press, 1986.
6. Adams J. Structure-activity and dose-response relationships in
the neural and behavioral teratogenesis of retinoids.
Neurotoxicol Teratol 15:193-202 (1993).
7. Adams J, Holson RR. The neurobehavioral teratology ofVitamin
A analogs. In: Handbook of Developmental Neurotoxicology
(Slikker WJ, Chang LW, eds). San Diego:Academic Press,
998;631-642.
8. Freeman JHJ, Barone SJ, Stanton ME. Cognitive and neu-
roanatomical effects oftriethyltin in developing rats: role of age
of exposure. Brain Res 634:85-95(1994).
9. Barone SJ. Developmental differences in neural damage fol-
lowing trimethyl-tin as demonstrated with GFAP immunohisto-
chemistry. Ann NYAcad Sci 679:306-316 (1993).
10. Freeman JHJ, Barone SJ, Stanton ME. Triethyltin produces
neural damage and cognitive deficits in developing rats that
depend on age of exposure. Brain Res 634:85-95(1994).
11. Meyer JS. Behavioral assessment in developmental neurotoxi-
cology: approaches involving unconditioned behaviors and phar-
macologic challenges in rodents. In: Handbook of
Developmental Neurotoxicology (Slikker WJ, Chang LW, eds).
San Diego: Academic Press, 1998;403-426.
12. Kimmel CA. Current approaches to risk assessment for develop-
mental neurotoxicology. In: Handbook of Developmental
Neurotoxicology (Slikker WJ, Chang LW, eds). San Diego:
Academic Press, 1998;675-686.
13. Adams J. Methods in behavioral teratology. In: Handbook of
Behavioral Teratology (Riley EP, Vorhees CV, eds). New
York:Plenum Press, 1986;67.
14. U.S. EPA. Health Effects Test Guidelines. OPPTS 870.6300
Developmental Neurotoxicity Study. Washington, DC:U.S.
Environmental Protection Agency, 1996.
15. Vorhees CV. Origins of behavioral teratology. In: Handbook of
Behavioral Teratology (Riley EP, Vorhees CV, eds). New
York:Plenum Press, 1986;3-22.
16. Vorhees CV. Principles of behavioral teratology. In: Handbook of
Behavioral Teratology (Riley EP, Vorhees CV, eds). New
York:Plenum Press, 1986; 23-48.
17. Buznikov GA, Shmukler Y, Lauder JM. Changes in the physio-
logical roles of neurotransmitters during individual develop-
ment. Neurosci Behav Physiol 29:11-21 (1999).
18. Rice DC, Barone SJ. Critical periods of vulnerability for the
developing nervous system: evidence from humans and animal
models. Environ Health Perspect 108:511-533 (2000).
19. Vorhees CV. Reliability, sensitivity and validity of behavioral
indices of neurotoxicity. Neurotoxicol Teratol 9:445-464 (1987).
20. Kimmel CA, Buelke-Sam J. Collaborative Behavioral Teratology
Study: background and overview. Neurobehav Toxicol Teratol
7:541-545(1985).
21. Holson RR. When is a rat a boy? In: Organ System Maturation
and Functional Postnatal Development: Aspects to Consider for
Pediatric Safety Assessment (Tassinari M, ed). Bethesda,
MD:Teratology Society, 1999;D11-D42.
22. Jensen KF, Catalano SM. Brain morphogenesis and develop-
mental neurotoxicology. In: Handbook of Developmental
Neurotoxicology (Slikker WJ, Chang LW, eds). San
Diego:Academic Press, 1998;3-42.
23. Bennett GD, Finnell GD. Periods of susceptibility to induced
malformations of the developing mammalian brain. In:
Handbook of Developmental Neurotoxicology (Slikker WJ,
Chang LW, eds). San Diego:Academic Press, 1998:189-208.
542 Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000CRITICAL PERIODS OF EXPOSURE IN THE DEVELOPING NERVOUS SYSTEM
24. Rodier PM. Neuroteratology of autism. In: Handbook of
Developmental Neurotoxicology (Slikker WJ, Chang LW, eds).
San Diego:Academic Press,1998;661-672.
25. Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J.
Embryological origin for autism: developmental anomalies of
the cranial nerve motor nuclei. J Comp Neurol 370:247-261
(1996).
26. Holson RR, Gazzara RA, Ferguson SA, Ali SF, Laborde JB,
Adams J. Gestational retinoic acid exposure: a sensitive period
for effects on neonatal mortality and cerebellar development.
Neurotoxicol Teratol 19:335-346 (1997).
27. Holson RR, Gazzara RA, Ferguson SA, Adams J. Behavioral
effects of low-dose gestational day 11-13 retinoic acid expo-
sure. Neurotoxicol Teratol 19:355-362 (1997).
28. Holson RR, Gazzara RA, Ferguson SA, Adams J. A behavioral
and neuroanatomical investigation of the lethality caused by
gestational day 11-13 retinoic acid exposure. Neurotoxicol
Teratol 19:347-353 (1997).
29. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun
JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT. Retinoic acid
embryopathy. N Engl J Med 313:837-841 (1985).
30. Dansky LV, Finnell RH. Parental epilepsy, anticonvulsant drugs,
and reproductive outcome: epidemiologic and experimental
findings spanning three decades. 2: Human studies. Reprod
Toxicol 5:301-335(1991).
31. Finnell RH, Dansky LV. Parental epilepsy, anticonvulsant drugs,
and reproductive outcome: epidemiologic and experimental
findings spanning three decades. 1: Animal studies. Reprod
Toxicol 5:281-299(1991).
32. Hansen DK, Holson RR. Developmental neurotoxicology of
antiepileptic drugs. In: Handbook of Developmental
Neurotoxicology (Slikker WJ, Chang LW, eds). San
Diego:Academic Press, 1998:643-660.
33. Kempermann G, Gage FH. New nerve cells for the adult brain.
Sci Am 280:48-53 (1999).
34. Barone SJ. Applications of the neurotrophic hypothesis to
developmental neurotoxicology. In: Target Organ Toxicity -
Neurotoxicology (Tilson HA, Harry GJ, eds). Washington,
DC:Taylor & Francis, 1999;179-200.
35. Barone SJ, Das KD, Lassiter TL, White LD. Vulnerable
processes of nervous system development: a review of markers
and methods. Neurotoxicology 21(1-2):15-36 (1999).
36. Dietrich K. Environmental toxicants and child development. In:
Neurodevelopmental Disorders: Contributions to a New
Framework from the Cognitive Neurosciences (Tager-Flusberg
H, ed). Cambridge, MA:MIT Press, 1999;469-490.
37. Bellinger D, Dietrich KN. Low level lead exposure and cognitive
function in children. Pediatr Ann 23)1 1):600-605 (1994).
38. Dietrich KN, Berger OG, Succop PA, Hammond PB, Bornshein
RL. The developmental consequences of low to moderate pre-
natal and postnatal lead exposure: intellectual attainment in
the Cincinnati Lead Study Cohort following school entry.
Neurotoxicol Teratol 15)1):37-44 (1993).
39. Rice DC. Behavioral effects of lead: commonalities between
experimental and epidemiologic data. Environ Health Perspect
104(suppl 2):337-351 (1996).
40. Rice DC. Developmental lead exposure: neurobehavioral conse-
quences. In: Handbook of Developmental Neurotoxicology
(Slikker WJ, Chang LW, eds). San Diego:Academic Press,
1998:539-557.
41. Dietrich KN, Succop PA, Bornschein RL, Krafft KM, Berger D,
Hammond PB, Buncher CR. Lead exposure and neurobehavioral
development in later infancy. Environ Health Perspect 89:13-19
(1990).
42. Averill D, Needleman H. Neonatal lead exposure retards corti-
cal synaptogenesis in the rat. In: Low Level Lead Exposure: The
Clinical Implications of Current Research (Needleman H, ed).
NewYork:Raven Press, 1980;210-219.
43. McCauley PT, Bull RJ, Tonti AP, Lutkenhoff SD, Meister MV,
Doerger JU, Stober JA. The effect of prenatal and postnatal
lead exposure on neonatal synaptogenesis in rat cerebral cor-
tex. J Toxicol Environ Health 10:639-651 (1982).
44. Hoff SF. Synaptogenesis in the hippocampal dentate gyrus:
effects of in utero ethanol exposure. Brain Res Bull 21:47-54
(1988).
45. Kawamoto JC, Overmann SR, Woolley DE, Vijayan VK.
Morphometric effects of preweaning lead exposure on the hip-
pocampal formation of adult rats. Neurotoxicology 5:125-148
(1984).
46. Audesirk G, Audesirk T. Neurite development. In: Handbook of
Developmental Neurotoxicology (Slikker WJ, Chang LW, eds).
San Diego:Academic Press, 1998;61-86.
47. Gilbert ME, Mack CM, Lasley SM. The influence of develop-
mental period of lead exposure on long-term potentiation in the
adult rat dentate gyrus in vivo. Neurotoxicology 20:57-69
(1999).
48. Johnston MV, Goldstein GW. Selective vulnerability of the
developing brain to lead. Curr Opin Neurol 11(6):689-693
(1998).
49. Cookman GR, King W, Regan CM. Chronic low level lead expo-
sure impairs embryonic to adult conversion of the neural cell
adhesion molecule. J Neurochem 49(2):399-403 (1987).
50. Harry GJ, Toews AD, Krigman MR, Morell P. The effect of lead
toxicity and milk deprivation of myelination in the rat. Toxicol
AppI Pharmacol 77:458-464 (1985).
51. Harry GJ, Toews AD. Myelination, dysmyelination, and demyeli-
nation. In: Handbook of Developmental Neurotoxicology (Slikker
WJ, Chang LW, eds). San Diego:Academic Press, 1998;87-116.
52. Cookman GR, Hemmens SE, Keane GJ, King WB, Regan CM.
Chronic low level lead exposure precociously induces rat glial
development in vitro and in vivo. Neurosci Lett 86(1):33-37
(1988).
53. Lasley SM, Green MC, Gilbert ME. Influence of exposure period
on in vivo hippocampal glutamate and GABA release in rats
chronically exposed to lead. Neurotoxicology 20:619-630
(1999).
54. Guilarte TR. The N-Methyl-D-aspartate receptor: physiology and
neurotoxicology in the developing brain. In: Handbook of
Developmental Neurotoxicology (Slikker WJ, Chang LW, eds).
San Diego:Academic Press, 1998;285-304.
55. Chang LW, Reuhl KR, Lee GW. Degenerative changes in the
developing nervous system as a result of in utero exposure to
methylmercury. Environ Res 14:414-423 (1977).
56. Burbacher TM, Rodier PM, Weiss B. Methylmercury develop-
mental neurotoxicity: a comparison of effects in humans and
animals. Neurotoxicol Teratol 12:191-202 (1990).
57. Chang LW, Guo TL. Fetal Minamata Disease. In: Handbook of
Developmental Neurotoxicolgy (Slikker WJ, Chang LW, eds).
San Diego:Academic Press, 998;507-516.
58. Barone SJr, Haykal-Coates N, Parran DK, Tilson HA. Gestational
exposure to methylmercury alters the developmental pattern of
trk-like immunoreactivity in the rat brain and results in cortical
dysmorphology. Dev Brain Res 109:13-31 (1998).
59. Haykal-Coates N, Shafer TJ, MundyWR, Barone S Jr. Effects of
gestational methylmercury exposure on immunoreactivity of
specific isoforms of PKC and enzyme activity during post-natal
development ofthe rat brain. Dev Brain Res 109:33-49(1998).
60. Mundy WR, Parran DK, Barone S Jr. Gestational exposure to
methylmercury alters the developmental pattern of neu-
rotrophin- and neurotransmitter-induced phosphoinositide (Pi)
hydrolysis. Neurotoxicol Res(in press).
61. Jernigan TL, Trauner DA, Hesselink JR, Tallal PA. Maturation of
human cerebrum observed in vivo during adolescence. Brain
114(Pt 5):2037-2049 (1991).
62. van Eden CG, Kros JM, Uylings HBM. The development of the
rat prefrontal cortex: its size and development of connections
with thalamus, spinal cord and other cortical areas. In: Vol. 85:
The Prefrontal Cortex: Its Structure, Function, and Pathology
(Uylings HBM, van Eden CG, DeBruin JPC, Corner MA, Feenstra
MGP, eds). Amsterdam:Elsevier, 1999j169-183.
63. Zecevic N, Rakic P. Synaptogenesis in monkey somatosensory
cortex. Cereb Cortex 1:510-523 (1991).
64. Lewis DA. Development of the prefrontal cortex during adoles-
cence: insights into vulnerable neural circuits in schizophrenia.
Neuropsychopharmacology 16:385-398(1997).
65. Andersen SL, Dumont NL, Teicher MH. Developmental differ-
ences in dopamine synthesis inhibition by (+)-7-DH-DPAT.
Naunyn-Schmeidelberg's Arch Pharmacol 356:173-181 (1997).
66. Teicher MH, Barber NI, Gelbard HA, Gallitano AL, Campbell A,
Marsh E, Baldessarini RJ. Developmental differences in acute
nigrostriatal and mesocorticolimbic system response to
haloperidol. Neuropsychopharmacology 9:147-156 (1993).
67. Benes FM. Myelination of cortical-hippocampal relays during
late adolescence. Schizophr Bull 15:585-593 (1989).
68. Dumas TC, Foster TC. Late developmental changes in the ability
of adenosine Al receptors to regulate synaptic transmission in
the hippocampus. Dev Brain Res 105:137-139(1998).
69. Choi S, Weisberg SN, Kellogg CK. Control ofendogenous norepi-
nephrine release in the hypothalamus of male rats changes over
adolescent development. Dev Brain Res 98:134-141 (1997).
70. Salimov RM, McBride WJ, McKinzie DL, Lumeng L, Li TK.
Effects of ethanol consumption by adolescent alcohol-preferring
P rats on subsequent behavioral performance in the cross-maze
and slip funnel tests. Alcohol 13:297-300(1996).
71. Goliszek AG, Crawford GE, Lawrence HS, Bennett J, Williams F,
Hurley SL. Effects of prepubertal stress on subsequent ACTH
response to novel stress and CRH in male vs female rats. Stress
Med 12:199-204)1996).
72. Spear LP. The adolescent brain and age-related behavioral
manifestations. Neurosci Behav Rev(in press).
73. Spear LP. Neurobehavioral changes in adolescence. Curr Dir
Psychol Sci (in press).
74. Rice DC. Age-related increase in auditory impairment in mon-
keys exposed in utero plus postnatally to methylmercury.
Toxicol Sci 44:191-196 (1998).
75. Rice DC, Hayward S. Comparison of visual function at adult-
hood and during aging in monkeys exposed to lead or
methylmercury. Neurotoxicology 20(5):767-784(1999).
76. Barone SJ, Stanton ME, Mundy WR. Neurotoxic effects of
neonatal triethyltin (TET) exposure are exacerbated with aging.
Neurobiol Aging 16:723-735 (1995).
77. Spear LP, Campbell J, Snyder K, Silveri M, Katovic N. Animal
behavior models. Increased sensitivity to stressors and other
environmental experiences after prenatal cocaine exposure.
Ann NYAcad Sci 846:76-88 (1998).
78. Strupp BJ, Himmelstein S, Bunsey M, Levitsky DA, Kesler M.
Cognitive profile of rats exposed to lactational hyperphenylala-
ninemia: correspondence with human mental retardation. Dev
Psychobiol 23:195-214(1990).
79. Strupp BJ, Bunsey M, Levitsky DA, Hamberger K. Deficient
cumulative learning: an animal model of retarded cognitive
development. Neurotoxicol Teratol 16:71-79 (1994).
80. Paule MG, Meck WH, McMillan DE, McClure GY, Bateson M,
Popke EJ, Chelonis JJ, Hinton SC. The use of timing behaviors
in animals and humans to detect drug and/or toxicant effects.
Neurotoxicol Teratol 21:491-502(1999).
81. Vorhees CV. Fetal anticonvulsant syndrome in rats: dose- and
period-response relationships of prenatal diphenylhydantoin,
trimethadione, and phenobarbitol exposure on the structural
and functional development of the offspring. J Pharmacol Exp
Ther 227:274-287 (1983).
82. Pennington BF. Attention deficit hyperactivity disorder. In:
Diagnosing Learning Disorders (Pennington BF, ed). New
York:Guilford Press, 1991;82-110.
83. Henderson MG, McConnaughey MM, McMillen BA. Long-term
consequences of prenatal exposure to cocaine or related drugs:
effects on rat brain monoaminergic receptors. Brain Res Bull
26:941-945 (1991).
84. Moody CA, Frambes NA, Spear LP. Psychopharmacological
responsiveness to the dopamine agonist quinpirole in normal
weanlings and in weanling offspring exposed gestationally to
cocaine. Psychopharmacol Ser(BerI) 108:256-262(1992).
85. Kelley BM, Groseclose CH, Middaugh lD. Prenatal cocaine
exposure increases the reinforcing strength of oral ethanol in
C57 mice. Neurotoxicol Teratol 19:391-398(1997).
86. Freeman JHJ, Barone SJ, Stanton ME. Disruption of cerebellar
maturation by an antimitotic agent impairs the ontogenyof eye-
blinkconditioning in rats. J Neurosci 15:7301-7314(1995).
87. Darr J. Ranking and Screening Risks in the OPPT Existing
Chemicals Program. Available: http://www.epa.gov/opptintr/
cie/ranking.htm [cited 6April 20001.
88. United Nations, Environmental Programme. Screening
Information Data Set. Available: http://irptc.unep.ch/irptc/sids/
sidspub.html [cited 18April 2000].
89. Susser E, Brown A, Gorman J. Prenatal Exposures in
Schizophrenia. Washington, DC:American Psychiatric Press,
(1999).
90. Susser EB, Brown A, Matte TD. Prenatal factors and adult men-
tal and physical health. Can J Psychiatry 44:326-334(1999).
91. Hoek HW, Brown AS, Susser E. The Dutch famine and schizo-
phrenia spectrum disorders. Soc Psychiatry Psychiatr Epidemiol
33:373-379 (1998).
92. Selten JP, Brown AS, Moons KG, Slaets JP, Susser ES, Kahn
RS. Prenatal exposure to the 1957 influenza pandemic and non-
affective psychosis in The Netherlands. Schizophr Res 38:85-91
(1999).
93. Keshavan MS, Hogarty GE. Brain maturational processes and
delayed onset in schizophrenia. Dev Psychopathol 11:525-543
(1999).
94. LaMantia AS. Forebrain induction, retinoic acid, and vulnerabil-
ity to schizophrenia: insights from molecular and genetic analy-
sis in developing mice. Biol Psychiatry 46:19-30 (1999).
95. Richardson GA, Day NL. Epidemiologic studies of the effects
of prenatal cocaine exposure on child development and
behavior. In: Handbook of Developmental Neurotoxicology
(Slikker WJ, Chang LW, eds). San Diego:Academic Press,
1998;487-496.
96. Hardy JF, Drage JS, Jackson EC. The First Year of Life: The
Collaborative Perinatal Project on the National Institute of
Neurological and Communicative Disorders and Stroke.
Baltimore:The Johns Hopkins University Press, 1979.
97. Fried PA, Makin JE. Neonatal behavioural correlates of prenatal
Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000 543ADAMS ETAL.
exposure to marihuana, cigarettes and alcohol in a low risk
population. Neurotoxicol Teratol 9:1-7 (1987).
98. Stanton ME, Spear LP. Workshop on the qualitative and quanti-
tative comparability of human and animal developmental neuro-
toxicity, Work Group report: comparability of measures of
developmental neurotoxicity in humans and laboratory animals.
Neurotoxicol Teratol 12:261-267 (1990).
99. Buelke-Sam J, Mactutus CF. Workshop on the qualitative and
quantitative comparability of human and animal developmental
neurotoxicity, Work Group 11 report: testing methods in develop-
mental neurotoxicity for use in human risk assessment.
Neurotoxicol Teratol 12:269-274 (1990).
100. Davis JM, Otto DA, Weil DE, Grant ID. The comparative devel-
opmental neurotoxicity of lead in humans and animals.
Neurotoxicol Teratol 12:215-229 (1990).
544 Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000